ABSTRACT Aim To present a new method called magnetolipofection which can transfect cells in a specific area of the retinal pigment epithelium (RPE) by magnetic force as a nonviral gene transfection. Methods ARPE-19 (a human RPE cell line) cells were cultured with a mixture of cationic lipid, plasmid DNAs and magnetite nanoparticles.
INTRODUCTION
More than half a century has passed since the discovery of DNA in 1944, and seminal studies in the clinical applications of gene therapy have been conducted on patients with adenosine deaminase (ADA) deficiency with very promising outcomes 50 years later. 1 In ophthalmology, gene therapy for retinal diseases was first tried in 1994, 2 and this was followed by a series of clinical studies that began in 2001 using adenoviruses as vectors to treat agerelated macular degeneration (AMD). 3 In 2008, gene therapy was reported to restore visual function to patients with Leber 's congenital amaurosis. 4 5 At present, viral vectors are used as the principal vectors in gene therapies including those on the eye. Ocular gene transfer is also without exception. 6 7 AMD affects the macular area of the retina, and if the area of gene transfection can be directed to this region, it would be more advantageous for gene therapy. Some experiments have shown that viral vectors can target specific areas of the retina, 8 9 but in spite of their relatively high infection efficiency, viral vectors remain difficult to generate. To overcome this difficulty, lipofection was introduced as an alternative for delivering genes to cells. 10 In this method, the DNAs of the targeted gene are conjugated by electrical interactions to liposomes which are bilayered vesicles composed of positively charged lipids. The liposomes have a high affinity for negatively charged cell membranes, and once in contact with the membranes, they are internalised by endocytosis. Other methods such as electroporation which uses electric pulses have also been tried. 11 12 These non-viral methods are still not completely satisfactory for in vivo transfection, but they are used because they are easier to manipulate, more economical and safer than viral vectors.
Magnetofection was developed to enhance the delivery of genes to targeted cells. 13 This method utilises magnetic beads and magnetic attraction. We have developed magnetite cationic liposomes (MCLs) containing magnetite nanoparticles. This takes advantage of not only the magnetic attraction but also electrostatic interactions of positively charged MCLs and negatively charged cell membrane. 14 15 MCLs have been used in thermotherapy, 16 tissue engineering 17 18 19 and other procedures. The purpose of this study was to develop a method to transfect a specific area of the retinal pigment epithelium (RPE) with a mixture composed of MCLs and plasmid DNA (pDNA/MCL).
METHODS

Cell cultures
A human RPE cell line, ARPE-19, was purchased from the American Type Culture Collection (ATCC). The cells were grown in a mixed medium of DMEM/Ham's F-12 (1:1) supplemented with 10% fetal bovine serum (FBS) and streptomycin/ penicillin G. The incubator was set to 378C, and the cells were grown under 5% CO 2 in air.
(TMAG), dilauroylphosphatidylcholine (DLPC) and dioleoylphosphatidylethanolamine (DOPE) were prepared at a molar ratio of 1:2:2 for a final concentration of 1 mm.
TMAG is a positively charged lipid. This solution was dissolved in 67 ml of chloroform, and the solvent was allowed to evaporate to leave a lipid membrane.
Then, 500 ml of phosphate-buffered saline (PBS), 20 mg of plasmid DNA (phr green fluorescent protein (GFP)-N1, which expresses humanised recombinant GFP under the control of the cytomegalovirus promoter) and magnetite nanoparticles (Fe 3 O 4 , 10 nm average particle size; Toda Kogyo, Hiroshima, Japan) were added to the lipid membrane. The mixture was vortexed to produce the pDNA/MCLs. The amount of magnetite nanoparticles was adjusted to 2.5, 5, 12.5, 25 or 50 pg/cell.
Gene transfer in vertical direction
The ARPE-19 cells were grown to confluence in 6-well plates (BD-Falcon, Franklin Lakes, New Jersey, USA), and pDNA/ MCLs was added to the medium. Then, a magnet (Neodymium magnet, NE050, F6 mm36 mm, 450 mt, Niroku-Seisakusho, Kobe, Japan) was placed beneath the centre of the plate for 5 or 30 min ( figure 1A ). The concentration of the magnetite nanoparticles in the medium was adjusted to 2.5, 5, 12.5, 25 or 50 pg/ cell. This gene transfer method is termed 'magnetolipofection'. As a control, Lipofectamine2000 (Invitrogen, Carlsbad, California, USA), which is the most commonly used agent for nonviral gene transfection, was used for the gene transfer. The concentrations of the plasmid DNA used were 2 mg/well for both magnetolipofection and lipofection.
After the magnet was removed, the medium in the plates was changed; 48 h later, the number of GFP positive cells was counted under a fluorescent microscope (n¼5).
Gene transfer in horizontal direction
The ARPE-19 cells were grown to confluence in culture flasks (IWAKI, Tokyo, Japan) by the same procedures. The flasks were placed vertically, and the pDNA/MCLs were added to the medium. Then, a magnet was placed along the side of the flasks to test whether gene transfer was possible in the horizontal direction (figure 1B). After placing the magnet for 5 or 30 min, the standing flask was returned to its initial flat position and the medium was changed; 48 h later, the number of GFP positive cells in the area that was submerged in the culture medium was counted under a fluorescent microscope (n¼5).
Cytotoxicity
To study the cytotoxic effects of MCLs, ARPE-19 cells were grown to subconfluence, and then subjected to magnetolipofection using the same procedures used for the vertical direction. The amount of magnetite nanoparticles was 25 pg/cell. After 3, 6 and 10 days of incubation, the number of living cells in the suspension was counted with a haemocytometer to produce a growth curve. 20 Using the 0.4% trypan blue exclusion staining method, the dead cells were positively stained and the alive cells were negative. For control, cells without transfection and cells transfected using Lipofectamine2000 were studied (n¼5).
RESULTS
Gene transfer in vertical direction
When magnetolipofection was performed in the vertical direction, the gene transfection was selective (figure 2A). In the central area where the magnet was placed for 5 min, the means of the cell counts for positive GFP signals were 204, 349, 215, 165 and 96 cells/field for magnetite nanoparticle concentrations of 50, 25, 12.5, 5 and 2.5 pg/cell, respectively. In the peripheral area where the magnet was not present, the means of the cell counts for positive GFP signals were 51, 37, 23, 22 and 17 cells/field for the same magnetite nanoparticle concentrations. The differences in the number of GFP-positive cells between the areas where a magnet was placed and where it was absent were significant (p<0.05 for all concentrations; Wilcoxon signed-rank test; figure 2B ).
When the magnet was applied for 30 min, the means of the cell counts for positive GFP signals were 287, 376, 312, 179 and 137 cells/field in the central area for magnetite nanoparticle concentrations of 50, 25, 12.5, 5 and 2.5 pg/cell, respectively (figure 2C).
When lipofection with Lipofectamine2000 was performed, the mean of the cell counts for positive GFP signals was 341 cells/field (figure 2B).
Gene transfer in horizontal direction
When magnetolipofection was performed in the horizontal direction, the gene transfection also occurred selectively ( figure 3A) . Almost no gene transfer was detected when lipofection using Lipofectamine2000 was performed (figure 3B).
Cytotoxicity
We used the trypan blue staining method at 3, 6 and 10 days after gene transfection, and counted the number of living cells. When gene transfer was performed by magnetolipofection, there were more living cells at any time tested. In addition, the findings were not altered by durations of 5 or 30 min using 25 pg/ cells of magnetite nanoparticles. However, when Lipofectamine2000 was used, a significant decrease in the number of living cells was observed (figure 4). 
DISCUSSION
When magnetolipofection was performed in the vertical direction, the efficiency of gene transfer increased in a dose-dependent way until the concentration of the magnetite nanoparticle reached 25 pg/cell. Thereafter, the degree of transfection saturated. Therefore, the optimal magnetite nanoparticle concentration for RPE cells was 25 pg/cell, and the difference in the number of GFPpositive cells at the two durations of magnetolipofection was not significant at this concentration (p>0.05; ManneWhitney U test; figure 2C ). Thus, the duration of magnetolipofection for 5 min may be sufficient for gene transfer in the vertical direction. When the concentration of the magnetite nanoparticle was 25 pg/cell, the transfection efficiency where the magnet was placed was equivalent to that transfected with Lipofectamine2000. Although there is a possibility that more cells were transfected by Lipofectione2000, those cells may have died because of the cytotoxicity of Lipofectamine2000. In any case, our findings indicate that similar amount of living transfected cells were produced by magnetolipofection and lipofection by Lipofectamine2000.
These results suggest that our method for RPE cells is as effective as other non-viral vectors, and can efficiently transfect cells in a specific area.
To extend this concept to the clinic for a three-dimensional object such as the eye, we have tested whether this method can be used in the horizontal direction. When magnetolipofection was performed in the horizontal direction, the efficiency of gene transfer was highest when the concentration of the magnetite nanoparticle was 25 pg/cell, and the optimal magnetite nanoparticle concentration for RPE cells was 25 pg/cell as it was for the vertical gene transfection. The difference in the number of GFP-positive cells for the two durations of magnetolipofection (5 min or 30 min) at this concentration was not significant (p>0.05; ManneWhitney U test; figure 3C ). On the other hand, almost no gene transfer was detected when Lipofectamine2000 was used. This may be because the liposomes had settled to the bottom of the flask, and were unable to transfect the cells in the horizontal direction.
From these results, we conclude that this method is applicable not only for vertical gene transfection but also for horizontal transfection. For patients with macula damage, for example, AMD, this method can be used to direct the genes to the macular area. On the other hand, for patients with impaired peripheral vision that is due to retinitis pigmentosa, gene transfer can be applied selectively for the peripheral regions of the retina. Thus, this method is flexible in directing of genes to the affected areas.
There are other selective gene transfer methods which have been reported, such as photochemical transfection 21e24 and ultrasound-mediated transfection.
25e27 However, the former method can be phototoxic because of the photochemical reactions in the cells. To study the potential cytotoxic effects of magnetolipofection, we have used the trypan blue staining method and counted the number of living cells after gene transfection. When gene transfer was performed by magnetolipofection, there seemed to be less cytotoxicity at any time tested. Although more experiments are needed to explain why there was a significant difference compared to controls, our results suggest that cell proliferation was not inhibited by magnetolipofection. 30 and normal human dermal fibroblasts. 30 When Lipofectamine2000 was used, a significant decrease in the number of living cells was observed (figure 4). Because the area of gene transfection was larger using Lipofectamine2000, a direct comparison between magnetolipofection and lipofection using Lipofectamine2000 could not be made.
Ultrasound-mediated transfection has been reported to be non-cytotoxic, however this method requires a miniaturised ultrasound machine for the posterior portion of the eye. When transfecting RPE cells beneath the macular by magnetolipofection, a macular buckle 31 can be used to hold the magnet in place, and it is easier to place the magnet in the peripheral area.
In conclusion, we have developed a method for efficient and selective gene transfer using magnetolipofection with pDNA/ MCLs as non-viral vectors This study was conducted in vitro, and examinations on living animal are needed to test the efficiency in vivo. However, this method should be considered for gene transfer to RPE cells with area specificity, and this technique can be used for both experimental and clinical applications. 
